Roche leaves POCT Market?
All postsUser login
Hot Rumors
Latest Rumors
Biotech News
- Air Pollution Tied To Hardening Of Arteries
- Use Of Anti-Epileptic Drug During Pregnancy Associated With Increased Risk Of Autism
- Childhood Meningitis Associated With Lower Levels Of Educational Achievement, Financial Self-Sufficiency In Adulthood
- Study Examines Methods, Procedures For Improved Diagnosis Of Ectopic Pregnancy
- Use Of Beta-Blockers Around Time Of Non-Cardiac Surgery Associated With Improved Outcomes For Higher-Risk Patients
They're still making a
They're still making a killing on Siemens customers who bailed and went to Roche.
Actually, Siemens going into Diagnostics six years ago has been a major cash cow for Roche. DX loses customers quarterly while Roche quite happily sucks them up.
Why should they do this? They
Why should they do this? They are # 1 in PT/INR, # 2 in CArdiology and just launched a metabolic syndrome instrument. They make lots of money with POCT.
ABG cobas 123 poct it's a
ABG cobas 123 poct it's a flop!!! Roche invested a large sum of money, but the result is a lousy instrument.
I have heard from Roche rapresentative that they are going to give up poct market.
Only 30% of their SDL came
Only 30% of their SDL came from it anyway, no biggy.
POX market?
POX market?
Post new comment